Form 4 for ANAB ANAPTYSBIO, INC
Accepted 2021-11-05 00:00:00 ET · period of report 2021-11-04 · accession 0001209191-21-063260 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-05 | 2021-11-04 | ANAB | LOUMEAU ERIC J | COO, GC | M - OptEx | $17.09 | +5,000 | 2,500 | New | +$85.5K |
| D | 2021-11-05 | 2021-11-04 | ANAB | LOUMEAU ERIC J | COO, GC | S - Sale+OE | $35.00 | -5,000 | 0 | -100% | -$175.0K |
| DM | 2021-11-05 | 2021-11-04 | ANAB | LOUMEAU ERIC J | COO, GC | M - OptEx | $0.00 | -5,000 | 7,500 | -40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-04 | M | A | 2,500 | $20.16 | 5,000 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-04 | S | D | 5,000 | $35.00 | 0 | D | — | — | |
| 3 | Common | Common Stock | 2021-11-04 | M | A | 2,500 | $14.02 | 2,500 | D | — | — | |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2021-11-04 | M | D | 2,500 | $0.00 | 85,500 | D | $14.02 · — to 2029-12-05 | 2,500 Common Stock | (F3) In addition to the remaining options to purchase 93,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 137,500 shares of common stock, which options vest according to their terms. (F2) The stock option vested and is exercisable as to 25% of the shares subject to the option on December 6, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2021-11-04 | M | D | 2,500 | $0.00 | 7,500 | D | $20.16 · — to 2030-07-12 | 2,500 Common Stock | (F3) In addition to the remaining options to purchase 93,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 137,500 shares of common stock, which options vest according to their terms. (F4) The stock option vested and is exercisable as to 25% of the shares subject to the option on July 15, 2021, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. |